Skip to main content

Advertisement

SpringerLink
Log in

Therapy for pediatric myocarditis

  • Published:
Current Treatment Options in Cardiovascular Medicine Aims and scope Submit manuscript

Optional statement

Pediatric myocarditis is most often associated with the acute or subacute onset of congestive heart failure in a previously healthy child. Myocarditis presenting with acute, severe symptomatology, termed fulminant myocarditis, has a high rate of recovery. Aggressive supportive care is indicated in fulminant myocarditis, including mechanical circulatory support. For subacute heart failure, supportive care remains the mainstay of therapy for myocarditis. A number of uncontrolled pediatric studies using both immunosuppressive therapy and/or immunomodulating therapy with intravenous gamma globulin have suggested these therapies are safe and useful in treating pediatric myocarditis. However, translating these results into recommended, routine therapy for pediatric myocarditis is complicated by the high rate of spontaneous improvement of myocarditis with supportive care, and the lack of demonstrable benefit for immunosuppressive and immunomodulating therapies in blinded, randomized, placebo-controlled trials in adult myocarditis. Heart transplantation remains the final therapeutic option for children with myocarditis and intractable severe heart failure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Feldman AM, McNamara D: Myocarditis. N Engl J Med 2000, 343:1388–1398. A recent and comprehensive review on the pathogenesis and treatment of myocarditis.

    Article  PubMed  CAS  Google Scholar 

  2. Liberthson RR: Sudden death from cardiac causes in children and young adults. N Engl J Med 1996, 334:1039–1044.

    Article  PubMed  CAS  Google Scholar 

  3. Gouton M, Difilippo S, Sassolas F, et al.: Acute infectious myocarditis in childhood: results from 2 series from Lyon. Arch Mal Coeur Vaiss 1995, 88:753–759.

    PubMed  CAS  Google Scholar 

  4. Nugent AW, Davis AM, Kleinert S, et al.: Clinical, electrocardiographic, and histologic correlations in children with dilated cardiomyopathy. J Heart Lung Transplant 2001, 20:1152–1157.

    Article  PubMed  CAS  Google Scholar 

  5. Batra AS, Epstein D, Silka MJ: The clinical course of acquired complete heart block in children with acute myocarditis. Pediatr Cardiol 2003, 24:495–497.

    Article  PubMed  CAS  Google Scholar 

  6. Dec GW Jr, Waldman H, Southern J, et al.: Viral myocarditis mimicking acute myocardial infarction. J Am Coll Cardiol 1992, 20:85–89.

    Article  PubMed  Google Scholar 

  7. Hoyer MH, Fischer DR: Acute myocarditis simulating myocardial infarction in a child. Pediatrics 1991, 87:250–253.

    PubMed  CAS  Google Scholar 

  8. Friedman RA, Kearney DL, Moak JP, et al.: Persistence of ventricular arrhythmia after resolution of occult myocarditis in children and young adults. J Am Coll Cardiol 1994, 24:780–783.

    Article  PubMed  CAS  Google Scholar 

  9. Tsirka AE, Trinkaus K, Chen SC, et al.: Improved outcomes of pediatric dilated cardiomyopathy with utilization of heart transplantation. J Am Coll Cardiol 2004, 44:391–397.

    Article  PubMed  Google Scholar 

  10. Nugent AW, Daubeney PEF, Chondros P, et al.: The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med 2003, 348:1639–1646.

    Article  PubMed  Google Scholar 

  11. Webber SA, Boyle GJ, Jaffe R, et al.: Role of right ventricular endomyocardial biopsy in infants and children with suspect or possible myocarditis. Br Heart J 1994, 72:360–363.

    PubMed  CAS  Google Scholar 

  12. Lipshlutz SE, Sleeper LA, Towbin JA, et al.: The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 2003, 348:1647–1655.

    Article  Google Scholar 

  13. Aretz HT, Billingham ME, Edwards WD, et al.: Myocarditis: a histopathologic definition and classification. Am J Cardiovasc Pathol 1987, 1:3–14.

    PubMed  CAS  Google Scholar 

  14. Pophal SG, Sigfusson G, Booth KL, et al.: Complications of endomyocardial biopsy in children. J Am Coll Cardiol 1999, 34:2105–2110.

    Article  PubMed  CAS  Google Scholar 

  15. Edelman RR: Contrast-enhanced MR imaging of the heart: overview of the literature. Radiology 2004, 232:653–668.

    Article  PubMed  Google Scholar 

  16. Mahrholdt H, Goedecke C, Wagner A, et al.: Cardiovascular magnetic resonance assessment of human myocarditis. A comparison of histology and molecular pathology. Circulation 2004, 109:1250–1258.

    Article  PubMed  Google Scholar 

  17. Bowles NE, Ni J, Kearney DL, et al.: Detection of viruses in myocardial tissues by polymerase chain reaction: evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 2003, 42:466–472.

    Article  PubMed  Google Scholar 

  18. Okabe M, Fukuda K, Arakawa K, et al.: Chronic variation of myocarditis associated with hepatitis C virus infection. Circulation 1997, 96:22–24.

    PubMed  CAS  Google Scholar 

  19. Kühl U, Pauschinger M, Bock T, et al.: Parvovirus B19 infection mimicking acute myocardial infarction. Circulation 2003, 108:945–950.

    Article  PubMed  CAS  Google Scholar 

  20. Kawai C: From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death. Circulation 1999, 99:1091–1100.

    PubMed  CAS  Google Scholar 

  21. Ito M, Kodama M, Masuko M, et al.: Expression of coxsackievirus and adenovirus receptor in hearts of rats with experimental autoimmune myocarditis. Circ Res 2000, 86:275–280.

    PubMed  CAS  Google Scholar 

  22. Noutias M, Fechner H, de Jonge H, et al.: Human coxsackie-adenovirus receptor is colocalized with integrins alpha(v)beta(3) and alph(v)beta(5) on the cardiomyocyte sarcolemma and upregulated in dilated cardiomyopathy. Circulation 2001, 104:275–280.

    Google Scholar 

  23. Badorff C, Lee GH, Lamphear BJ, et al.: Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med 1999, 5:320–326.

    Article  PubMed  CAS  Google Scholar 

  24. Wojnicz R, Nowalany-Kozielska E, Wojciechowaska C, et al.: Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy. Circulation 2001, 104:39–45.

    PubMed  CAS  Google Scholar 

  25. Lauer B, Schannwell M, Kühl U, et al.: Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. J Am Coll Cardiol 2000, 35:11–18.

    Article  PubMed  CAS  Google Scholar 

  26. McCarthy RE, Boehmer JP, Hruban RH, et al.: Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000, 342:690–695.

    Article  PubMed  Google Scholar 

  27. Rosenthal D, Chrisant MRK, Edens E, et al.: International Society for Heart and Lung Transplantation: practice guidelines for management of heart failure in children. J Heart Lung Transplant 2004, 23:1313–1333. Summarizes evidence-based guidelines for various therapies for pediatric heart failure.

    Article  PubMed  Google Scholar 

  28. Rosenzweig EB, Starc Tj, Chen JM, et al.: Intravenous arginine-vasopressin in children with vasodilatory shock after cardiac surgery. Circulation 1999, 100:II182-II186.

    PubMed  CAS  Google Scholar 

  29. Feingold B, Law YM: Nesiritide use in pediatric patients with congestive heart failure. J Heart Lung Transplant 2004, 23:1455–1459.

    Article  PubMed  Google Scholar 

  30. Duncan BW, Bohn EJ, Atz AM, et al.: Mechanical circulatory support for the treatment of children with acute fulminant myocarditis. J Thorac Cardiovasc Surg 2001, 122:440–448.

    Article  PubMed  CAS  Google Scholar 

  31. Duncan BW: Mechanical circulatory support for infants and children with cardiac disease. Ann Thorac Surg 2002, 73:1670–1677.

    Article  PubMed  Google Scholar 

  32. Fiser WP, Yetman AT, Gunselman RJ, et al.: Pediatric arteriovenous extracorporeal membrane oxygenation (ECMO) as a bridge to cardiac transplantation. J Heart Lung Transplant 2003, 22:770–777.

    Article  PubMed  Google Scholar 

  33. Chen YS, Yu HS, Huang SC, et al.: Experience and result of extracorporeal membrane oxygenation in treating fulminant myocarditis with shock: what mechanical support should be considered first? J Heart Lung Transplant 2005, 24:81–87.

    Article  PubMed  Google Scholar 

  34. Stiller B, Dahnert I, Weng Y, et al.: Children may survive severe myocarditis with prolonged use of biventricular assist devices. Heart 1999, 82:237–240.

    PubMed  CAS  Google Scholar 

  35. Reinhartz O, Copeland JG, Farrar DJ: Thoratec ventricular assist devices in children with less than 1.3 m2 body surface area. ASAIO J 2003, 49:727–730.

    Article  PubMed  Google Scholar 

  36. Matsumori A, Igata H, Ono K, et al.: High doses of digitalis increase the myocardial production of proinflammatory cytokines and worsen myocardial injury in viral myocarditis: a possible mechanism of digitalis toxicity. Jpn Circ J 1999, 63:2476–2478.

    Google Scholar 

  37. Adams KF Jr, Gheorghiade M, Uretsky BF, et al.: Clinical benefits of low serum digoxin on the treatment of heart failure. J Am Coll Cardiol 2002, 39:946–953.

    Article  PubMed  CAS  Google Scholar 

  38. Bruns LA, Chrisant MK, Lamour JM, et al.: Carvedilol as therapy in pediatric heart failure: an initial multicenter experience. J Pediatr 2001, 138:505–511.

    Article  PubMed  CAS  Google Scholar 

  39. Rusconi P, Gomez-Marin O, Rossique-Gonzalez M, et al.: Carvedilol in children with cardiomyopathy: 3 years experience in a single institution. J Heart Lung Transplant 2004, 23:832–838.

    Article  PubMed  Google Scholar 

  40. Shaddy RE, Curtin EL, Sower B, et al.: The pediatric randomized carvedilol trial in children with chronic heart failure: rationale and design. Am Heart J 2002, 144:383–389.

    Article  PubMed  CAS  Google Scholar 

  41. Maisch B, Herzum M, Hufnagel G, et al.: Immunosuppressive treatment for myocarditis and dilated cardiomyopathy. Eur Heart J 1995, 16(suppl O):153–161.

    PubMed  CAS  Google Scholar 

  42. Cooper JT Jr: Giant cell myocarditis: diagnosis and treatment. Herz 2000, 25:291–298.

    Article  PubMed  Google Scholar 

  43. Galiuto L, Enriquez-Sarano M, Reeder GS, et al.: Eosinophilic myocarditis manifesting as myocardial infarction: early diagnosis and successful treatment. Mayo Clin Proc 1997, 72:603–610.

    Article  PubMed  CAS  Google Scholar 

  44. Liu PP, Mason JW: Advances in the understanding of myocarditis. Circulation 2001, 104:1076–1082. Summarizes recent work in murine models linking myocardial viral infection with the development of dilated cardiomyopathy.

    PubMed  CAS  Google Scholar 

  45. Mason JW, O’Connell JB, Herskowitz A, et al.: A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 1995, 333:269–275.

    Article  PubMed  CAS  Google Scholar 

  46. Parillo JE: Inflammatory cardiomyopathy (myocarditis). Which patients should be treated with anti-inflammatory therapy? Circulation 2001, 104:4–6.

    Google Scholar 

  47. Heart Failure Society of America (HFSA) practice guidelines: HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction-pharmacologic approaches [no authors listed]. J Card Fail 1999, 5:357–382.

  48. Frustaci A, Chimenti C, Calabrese F, et al.: Immunosuppressive therapy for active lymphocytic myocarditis. Virological and immunological profile of responders versus nonresponders. Circulation 2003, 107:857–863.

    Article  PubMed  Google Scholar 

  49. Hia CP, Yip WC, Tai BC, Quek SC: Immunosuppressive therapy in acute myocarditis: an 18-year systematic review. Arch Dis Child 2004, 89:580–584. An excellent summary of the experience with differing immunosuppression protocols in pediatric myocarditis.

    Article  PubMed  CAS  Google Scholar 

  50. Gagliardi MG, Bevilacqua M, Bassano C, et al.: Longterm follow up of children with myocarditis treated by immunosuppression and of children with dilated cardiomyopathy. Heart 2004, 90:1167–1171.

    Article  PubMed  Google Scholar 

  51. Burch M: Immune suppressive treatment in paediatric myocarditis: still awaiting the evidence. Heart 2004, 90:1103–1104.

    Article  PubMed  CAS  Google Scholar 

  52. Newburger JW, Sanders SP, Burns JC, et al.: Left ventricular contractility and function in Kawasaki syndrome: effect of intravenous gamma globulin. Circulation 1989, 79:1237–1246.

    PubMed  CAS  Google Scholar 

  53. Drucker NA, Colan SD, Lewis AB, et al.: Gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation 1994, 89:252–257.

    PubMed  CAS  Google Scholar 

  54. McNamara DM, Rosenblum WD, Janosko KM, et al.: Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy. Circulation 1997, 95:2476–2478.

    PubMed  CAS  Google Scholar 

  55. McNamara DM, Holubkov R, Starling RC, et al.: Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation 2001, 103:2254–2259.

    PubMed  CAS  Google Scholar 

  56. Kühl U, Pauschinger M, Schwimmbeck PL, et al.: Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 2003, 107:2793–2798.

    Article  PubMed  CAS  Google Scholar 

  57. Lee KJ, McCrindle BW, Bohn DJ, et al.: Clinical outcomes of acute myocarditis in childhood. Heart 1999, 82:226–233.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Division of Cardiology, Washington University School of Medicine, One Children’s Place, Suite 11W45, 63110, St. Louis, MO, USA

    Charles E. Canter MD

Authors
  1. Charles E. Canter MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Canter, C.E. Therapy for pediatric myocarditis. Curr Treat Options Cardio Med 7, 411–417 (2005). https://doi.org/10.1007/s11936-005-0025-z

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11936-005-0025-z

Keywords

Search

Navigation